COX-2 inhibitors have also recently been suggested [9] as possible alternatives to glucocorticoids in the treatment of peritumoral edema in patients with malignant brain tumours, as they showed that glioma-infiltrating microglia are a major source of PGE2 production through the COX-2 pathway. The gene discussed is PTGS2; the disease is central nervous system cancer.